Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications (Q33813174)

29 July 2017

1 reference

title

Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications (English)

1 reference

29 July 2017

Bjorkman DJ

1

1 reference

PubMed ID

10628588

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Medicine

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

6A

1 reference

29 July 2017

3S-8S; discussion 8S-10S

1 reference

Ulcer complications and nonsteroidal anti-inflammatory drugs

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Non-steroidal anti-inflammatory drugs and peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Rising frequency of ulcer perforation in elderly people in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Nonsteroidal Anti-Inflammatory Drugs and Gastrointestinal Disease: Pathophysiology, Treatment and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Misoprostol and nonsteroidal anti-inflammatory drugs: a tale of effects, outcomes, and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900362-9

10.1016/S0002-9343(99)00362-9

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10628588